Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079)

已完结 10 由小花花发布于 2026/3/29 14:40:35

DOI:10.1016/j.ygyno.2022.04.011
作者：Terumi Tanigawa , Nobuhiro Takeshima , Hideki Ishikawa , Shin Nishio , Tomoka Usami , Takaharu Yamawaki , Tetsuro Oishi , Kei Ihira , Hisamori Kato , Mayak
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：ObjectiveThis multicenter, open-label, phase II study aimed to evaluate the efficacy and safety of paclitaxel–carboplatin, bevacizumab, and bevacizumab-based maintenance therapy for metastat

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:SageSuccess and Failure in Blockchain-Based Interorganizational Ecosystems: A Governance Perspective